Affinity DataKi: 120nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 400nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 1.50E+3nMAssay Description:The compound was tested for irreversible inhibition of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 1.80E+3nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 1.80E+3nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 1.90E+3nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 9.00E+3nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 2.50E+4nMAssay Description:The compound was tested for binding affinity of Human Rhinovirus (HRV) 3C Protease.More data for this Ligand-Target Pair
Affinity DataKi: 1.04E+5nMAssay Description:Inhibition of Human Rhinovirus (HRV-14) 3C ProteaseMore data for this Ligand-Target Pair
Affinity DataEC50: >3.20E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 5.60E+3nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 2.00E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >2.00E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >2.20E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 2.80E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 600nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.00E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 5.60E+3nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.59E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 2.50E+3nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >1.50E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 5.80E+3nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 3.20E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 5.00E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.00E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >7.10E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+3nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.50E+5nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.00E+4nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair
Affinity DataEC50: 1.00E+3nMAssay Description:Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14More data for this Ligand-Target Pair